Results

Total Results: 2,110 records

Showing results for "risks".

221. Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_policymaker.pdf
     August 01, 2016 - acamprosate and oral naltrexone are not suitable or to individuals who prefer disulfiram and understand its risks … ü» Epidemiological studies consistently related heavy alcohol consumption to an increased risk of serious … number; SOE = strength of evidence a This column only includes studies rated as having a low or medium risk … included in the main analysis; these numbers do not include studies rated as having a high or unclear risk

222. Methods Guide for Medical Test Reviews Chapter 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
     July 01, 2012 - Awareness of these varied outcomes affects how a decisionmaker balances the benefits and risks of the … consider a broad range of outcomes to illustrate how these may affect the balance of the benefits and risks … In this example, the comparison test carries comparable or greater risks. … tests than for screening or medical tests if the test yields more specific information about mortality risk

223. Appendix A - The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease-appendix-a.pdf
     August 31, 2023 - Appendix A - The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease

224. Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_disposition-comments.pdf
     July 03, 2012 - Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment Source: http … Review Disposition of Comments Report Research Review Title: Multigene Panels in Prostate Cancer Risk … Multigene Panels in Prostate Cancer Risk Assessment. … and other clinical risk assessment test.” … The risk significance will certainly increase once the actual causal variant has been identified.

225. MEDLINE Searches (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
     March 01, 2009 - Estimating risks and benefits. Cancer 2005;103(6):1147-1153. No relevant outcomes 52. … Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results. … The estimation and use of absolute risk for weighing the risks and benefits of selective estrogen receptor … Tamoxifen and breast cancer prevention: are we aware of the risks? … ‡IBIS: 2-fold relative risk for ages 45 to 70, 4-fold relative risk for ages 40 to 44, 10-fold relative

226. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacological Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
     April 15, 2021 - In response, the EPC added a table to the discussion section on absolute risks of harms when available … presented in the context of the likelihood that this complication will occur and the difference in the relative … column whether the effect is a benefit or a harm and indicate the magnitude of effect in terms of relative … risks in the results column. … The key information about treatment risks, harms, and evidence can still be provided without relying

227. Appendix K Rapid Evidence Review Treatments for Clostridium difficile Colitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
     February 01, 2018 - (www.uphs.upenn.edu/cep/methods) Data synthesis (calculation of relative risks and confidence intervals … exploration of heterogeneity): Qualitative, including descriptive evidence tables with applicable relative … risks from studies, but not de novo calculations. … GEIH-CDI score may predict risk for recurrent C. … Additional risk factors to identify severe disease and increased mortality risk include leukopenia (

228. Title (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/obesity-child_research-protocol.pdf
     March 31, 2010 - 5 However, the patterns are complicated, and not all low-income or minority groups are at high risk …  Poor (high risk of bias). … differences or relative risks using a DerSimonian and Laird random effects model. … differences or relative risks with 95% confidence. … of the degree to which the study population, interventions, outcomes, and settings are relevant to risks

229. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - What are the comparative risks, benefits, and outcomes of therapies? … However, the adjusted relative risk of surgery-related complications was lower in patients treated … What are the comparative risks, benefits, and outcomes of therapies? … What are the comparative risks, benefits, and outcomes of therapies? … However, the adjusted relative risk of surgery-related complications was lower in patients treated

230. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - What are the comparative risks, benefits, and outcomes of therapies? … However, the adjusted relative risk of surgery-related complications was lower in patients treated … What are the comparative risks, benefits, and outcomes of therapies? … What are the comparative risks, benefits, and outcomes of therapies? … However, the adjusted relative risk of surgery-related complications was lower in patients treated

231. Medical-Evidence-Communication Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-evidence-communication_research-protocol.pdf
     July 31, 2012 - • Absolute relative risk and relative risk reduction are more understandable than number needed to … treat presentations.18-22 • Absolute relative risk tends to be less persuasive than relative risk reduction … the strength of evidence (also called ambiguity), uncertainty about the significance of particular risks … severity), uncertainty about the complexity of information (e.g., the multiplicity or stability of risks … ), and uncertainty resulting from ignorance about risks.

232. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - Hb response rates: Number of studies reporting 6 15 3 Patients analyzed 2,205 3,293 659 Pooled relative … Transfusion rates: Number of studies reporting 6 34 4 Patients analyzed 2,158 5,210 950 Pooled relative … Thromboembolic events: Number of studies reporting 3 30 1 Patients analyzed 1,879 6,092 314 Pooled relative … meaningfully different. 3 Since there was only one trial, this result is a single-study (not pooled) relative … risk.

233. Comparative Effectiveness of Strategies to De-escalate Aggressive Behavior in Psychiatric Patients in Acute Care Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
     October 01, 2016 - First is how to best balance the benefits and risks of seclusion or restraints with those of various … seclusion and mechanical restraint.44 CI = confidence interval; N = number; NR = not reported; RR = relative … risk; vs. = versus. … CI = confidence interval; KQ = Key Question; N = number; RR = relative risk; vs. = versus. … confidence interval; CRT= cluster randomized trial; KQ = Key Question; N = number; NR = not reported; RR = relative

234. Communication and Dissemination Strategies To Facilitate the Use of Health-Related Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-evidence-communication_executive.pdf
     November 01, 2013 - Risk-of-Bias Assessment of Individual Studies Two reviewers independently rated the risk of bias of … uncertainty are as follows: • Communicating precision—Studies found mixed effects of presenting numeric risks … Benefts for me or risks for others: a cross- culture investigation of the effects of message frames and … Does information about risks and benefts improve the decision-making process in cancer screening - … Impact of information about risks and benefts of cancer screening on intended participation.

235. Migraine-Prevention Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
     June 01, 2013 - Using Meta-Analyst and STATA® software, we calculated the relative risk and absolute risk difference … We evaluated the strength of the association a priori, defining a large effect as having relative risk … >2 and a very large effect as having relative risk >5.21 We defined low magnitude of effect as having … relative risk that was significant but <2. … Future studies should also specifically examine the effects and risks of off-label drug use for migraine

236. Ced-Appendix-3 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-appendix-3.xlsx
     June 24, 2022 - ’s local data warehouse and research portfolio, which may include legal counsel to manage liability risk … NAM2019 What special vulnerabilities or risks are anticipated in the study population? … NAM2019 The risk/benefit ratio of trial participation? … Generally, an intervention is not reasonable and necessary if its risks outweigh its benefits. … Generally, an intervention is not reasonable and necessary if its risks outweigh its benefits.

237. Disposition of Comments CER 214 Stroke Prevention in Patients With Atrial Fibrillation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
     October 30, 2019 - As mentioned above, I believe there is a gap in research on the relative risks and benefits of anticoagulation … clear that the key quantities needed for rational treatment choice are the differences in absolute risks … of risk. … Results Would be helpful to report absolute rates of major CVA and major bleeds to help interpret the relative … Given the amount of evidence we have focused our report on the relative risk estimates. 129.

238. Stroke Prevention in Atr ial Fibr illation Patients: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
     October 27, 2017 - Treatment Description to better understand the relative … risks and benefits of these drugs based on individual patient characteristics. … A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up … "[Mesh] OR risk[tiab] OR risks[tiab] OR "Predictive Value of Tests"[Mesh] OR predict[tiab] OR predicts … "[Mesh] OR risk[tiab] OR risks[tiab] OR "Safety"[Mesh] OR safety[tiab] OR safe[tiab] OR "Incidence"[

239. Research Protocol: Radiation Therapy for Brain Metastases (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
     October 10, 2019 - risks (RRs), and hazard ratios (HRs). … risks. … Deaths due to brain metastases (number of patients, relative risk) 5. … Key results that are based on measure-independent effect estimates, such as relative risks or standardized … of bias RR relative risk SD standard deviation SMD standardized mean difference SRS stereotactic

240. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
     April 01, 2020 - Harms and adverse events: – What are the risks of nonopioid pharmacologic agents for harms including … points on a 0 to 100-point scale • SMD >0.8 • RR/OR ≥2.0 MD = mean difference; OR = odds ratio; RR = relative … response with SNRI antidepressants (odds ratio [OR] 1.61 to 2.33) while we found a moderate effect (relative … ).15 Differences in magnitude could be due to the addition of 15 studies in our report, reporting relative … risks rather than odds ratios, and using direct comparisons rather than network analysis.